Paris, France

Jean-Noel Telles

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Biomerieux, Inc., Assistance Publique-Hopitaux De Paris, Other. Active years: 2004-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Noel Telles. Retrieved from https://idiyas.com/inventor/jean-noel-telles

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Paris, FR (2004 - 2009)
  • Brignais, FR (2012)

Company Filing History:


Years Active: 2004-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jean-Noel Telles

Introduction

Jean-Noel Telles is a prominent inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the diagnosis of viral infections. With a total of 3 patents, Telles has focused on developing methods and tools that enhance the detection and treatment of diseases.

Latest Patents

One of Telles' latest patents involves the development of oligonucleotides for diagnosing the presence of H5 and N1 genes of the Influenza A virus. This invention relates to a double pair of oligonucleotides designed to amplify two target sequences located in the H5 and N1 genes of the Influenza A virus genome. The oligonucleotides range in length from 10 to 50 nucleotides and include at least one fragment of 10 consecutive nucleotides derived from specific sequences. This invention is particularly applicable in the field of diagnosis, providing a method and kit for detecting the presence of these viral genes.

Another notable patent by Telles is a method for measuring the resistance of a patient with HIV-2 to protease inhibitors. This method involves searching for possible resistance in a biological sample containing an HIV-2 viral strain. The presence of mutations at specified positions in the protease protein sequence indicates resistance to anti-protease agents in the patient.

Career Highlights

Throughout his career, Jean-Noel Telles has worked with reputable organizations such as bioMérieux, Inc. and Assistance Publique-Hôpitaux de Paris. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to advancements in medical diagnostics.

Collaborations

Telles has collaborated with notable colleagues, including Francoise Brun-Vezinet and Diane Descamps. These partnerships have further enriched his research and innovation efforts.

Conclusion

Jean-Noel Telles is a distinguished inventor whose work has significantly impacted the field of biotechnology. His innovative patents and collaborations demonstrate his commitment to advancing medical diagnostics and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…